Submit Manuscript Now
Current issue Archive Authors Profile
Research Articles Supplement 3 · 2014 · pp. 49–57 · Issue page

IMPLICATIONS OF UTERINE ARTERY EMBOLIZATION FOR UTERINE FIBROMATOSIS

DI
Diana VOICU1
LI
Liviu POPOVICI2
DR
Dragos DAVITOIU3
IO
Ioana ROTAR4
1 MD, Department of Obstetrics and Gynecology, University Emergency Hospital Bucharest, Romania
2 MD, PhDc, Department of Obstetrics and Gynecology, University Emergency Hospital Bucharest, Romania
3 MD, PhD, Department of Surgery, University Emergency Hospital Bucharest, Romania
4 Assistant Professor MD, PhD, Department of Obstetrics and Gynecology, University of Medicine and Pharmacy “Iuliu Hatieganu” Cluj-Napoca, Romania
Accepted 27 March 2026
Available Online 15 December 2014
Abstract
THE PRESENT STUDY EXAMINES THE FAVORABLE EFFECT OF UTERINE ARTERY EMBOLIZATION IN MINIMALLY INVASIVE TREATMENT OF SYMPTOMATIC UTERINE FIBROIDS AT WOMEN AGED BETWEEN 20 AND 70 YEARS. ARE PRESENTED P ATHOLOGICAL ASPECTS, TECHNIQUE AND COMPLICATIONS AND CONSEQUENCES OF THE UTERINE EMBOLIZATION. CONCLUSION. UTERINE ARTERY EMBOLIZATION RESULTS IN A REDUCTION OF THE VOLUME OF MYOMAS AND IS NEEDED ESPECIALLY AS A PRIMARY THERAPY BUT CAN ALSO BE USED AS ADJUNCTIVE THERAPY IN THE UTERUS CONSERVATIVE INTERVENTIONS FOR REDUCING THE NUMBER OF TOTAL HYSTERECTOMIES IN FAVOR OF CONSERVATIVE MYOMECTOMY. IN THE STUDY GROUP WE OBSERVED NORMALIZATION OF MENSTRUAL CYCLES SINCE THE FIRST TWO MENSTRUAL CYCLES IN A 70% OF PAT IENTS AND THE EFFICACY WAS 88% ON REDUCTION THE MENOMETRORRHAGIA.
Keywords
UTERINE ARTERY EMBOLIZATION UTERINE FIBROID METRORRHAGIA.
Full Text
The body of this article is intentionally hidden on the public page. Please use the PDF reader or the PDF download for the complete text.
References
[1]
Greenberg MD, Kazamel TI – Medical and socioeconomic impact of uterine fibroids. Obstet Gynecol Clin North Am, 1995; 22:625-36
[2]
J.H. Ravina, A. Aymard - „Embolisation artérielle particulaire: un nouveau traitement des hémorragies des léiomyomes utérins”, La Presse Medicale, Tome 27, No 7, pp. 299-304, 1998.
[3]
Goodwin S. – „Uterine artery embolizatio n for the treatment of uterine leiomyomata embolization”, Cardiovasc Int Rad, 2003, 26(6):522-7.
[4]
Kempson RL, Hendrickson MR: Smooth muscle, endometrial stromal, and mixed Müllerian tumors of the uterus. Mod Pathol 2000, 13(3):328–342.
[5]
Parker WH : Etiology, symptomatology, and diagnosis of uterine myomas. Fertil Steril 2007, 87(4):725–36. Review
[6]
Florin Stamatian - Obstetrica şi Ginecologie, Ginecologie vol II, ed Echinox, cap XLVI, 488-495
[7]
Kjerulff KH, Erickson AB, Langerberg PW – Chronic gynecologic conditions reported by US women: Findings from the National Health Interview Survey, 1984 to 1992. Am J Public Health, 1996; 86:195-6.
[8]
Rein MS, Barbieri RL, Friedman AJ : Progesterone: a critical role in the pathogenesis of uterine myomas. Am J Obstet Gynecol 1995, 172(1 Pt 1):14–18.
[9]
Andersen J: Growth factors and cytokines in uterine leiomyomas. Semin Reprod Endocrino l 1996, 14(3):269–282.
[10]
Fields KR, Neinstein LS: Uterine myomas in adolescents: case reports and a review of the literature. J Pediatr Adolesc Gynecol 1996, 9(4):195–198.
[11]
Cramer SF, Patel A: The frequency of uterine leiomyomas. Am J Clin Pathol 1990, 94(4):435–438.
[12]
Farquhar CM, Steiner CA : Hysterectomy rates in the United States 1990 –1997. Obstet Gynecol 2002, 99(2):229–234.
[13]
Merrill RM: Hysterectomy surveillance in the United States, 1997 through 2005. Med Sci Monit 2008, 14(1):CR24-CR31.
[14]
Pelage JP, Le Dref O, Soyer P si colab. - Fibroid-related menorrhagia: Treatment with superselective embolization of the uterine arteries and midterm follow-up. Radiology,2000; 215:428-431.
[15]
Wilcox LS, Koonin LM, Pokras R, Strauss LT, Xia Z, Peterson HB – Hysterectomy in the United States, 1988-1990. Obstet Gynecol, 1994; 83:549-55.
[16]
Broder MS, Kanouse DE, Mittman BS, Bernstein SJ – The appropriateness of recommendations for hysterectomy in Southern California. Obstet Gynecol, 2000; 95:199-205.
[17]
Vessey MP, Villard -Mackintosh L, Macpherson K, Coulter A, Yeates D – The epidemiology of hysterectomy: findings in a large cohort study. Br J Obstet Gynaecol, 1992; 99:402-7.
[18]
Worthington-Kirsch RL, Hutchins FL, Popky GL - Uterine artery embolization for the management of leiomyomas: quality of life assessment and clinical response. Radiology,1998; 208:625-629.
[19]
Ravina JH, Aymard A, Ciraru -Vigneron N si colab . - Arterial embolization of uterine myoma: results apropos of 286 cases. J Gynecol Obstet Biol Reprod, 2000; 29:272-275.
[20]
Klein A, Schw artz ML - Uterine artery embolization for the treatment of uterine fibroids: an outpatient procedure. Am J Obstetr Gynecol, 2001; 184:1556-60.
[21]
Du J, Zuo Y, Chen X, Hu X, Lin H, Luo P, Hong D – Clinical observation of transcatheter uterine artery embolization for uterine myoma. Zhonghua Fu Chan Ke Za Zhi, 2002; 37(1):12-5.
[22]
Spies JB, Benenati JF, Worthington -Kirsch RL, Pelage JP – Initial Experience with Use of Tris - acryl Gelatin Microspheres for Uterine Artery Embolization for Leiomyomata. J Vasc Interv Radiol, 2001; 12(9):1059-1063.
[23]
D Iacob – „L’embolisation des artères utérines dans le traitement de myomes utérins: état des lieuse”, Gynéc Obstét Fertilité, 2004, vol 52, No 11, pag 927-935.
[24]
Yuri Kitamura M.D., Susan M. Ascher - „Imaging manifestations of complications associated with uterine artery embolization”, Radio Graphics, 2005, 25:S119-S132.
[25]
Spies JB - New Trends in the Management of Uterine Fibroids. Presented at the 3rd World Congress on Controversies in Obstetrics, Gynecology & Infertility meeting in Washington, DC,